Cancer-Help.org provides news and information on cancer,   gathering articles on hundreds of cancer-related topics   from more than 1,500 sources across the web.

Here and Now: Inspiring Stories of Cancer Survivors -- by Elena Dorfman, Heidi Schultz Adams Kathy's Hats: A Story of Hope Kathy's Hats: A Story of Hope by Trudy Krisher My Mommy's Cancer by Cindy Klein Cohen Beating Cancer With Nutrition by Patrick Quillin A Cancer Battle Plan: Six Strategies for Beating Cancer, from a Recovered "Hopeless Case" by Anne E. Frahm, David J. Frahm How to Fight Cancer & Win by William L. Fischer What to Eat if You Have Cancer by Daniella Chace The Cure for All Cancers: Including over 100 Case Histories of Persons Cured by Hulda Regehr Clark Just Get Me Through This: The Practical Guide to Breast Cancer by Deborah A. Cohen

AE-941 A substance made from shark cartilage that is being studied for its ability to prevent the growth of new blood vessels to solid tumors. It belongs to the family of drugs called angiogenesis inhibitors. (National Cancer Institute) Oncology Drug Development Update - Over 142 Records of Novel Drugs ... Feb 16, 2005 Updates http://nmok.net/updates/newdrugJan05.html New Drug records updated in January 2005 include: 2C3, 3G4, A6 project, ABT-751 (E7010), AE-941, AEE788, AES ... PR Newswire (press release) Oncology Drug Development Update - Over 142 Records of Novel Drugs ... Feb 16, 2005 2C3, 3G4, A6 project, ABT-751 (E7010), AE-941, AEE788, AES-14, AG-013736, AGRO100, AMG 706, AMN107, AN-152, AN-238 and AN-162, AP23573, APC8015, ARQ 501 ... Yahoo News (press release) Resources from the National Cancer Institute on AE-941: Cancer.gov  Phase III Randomized Study of AE-941 (Neovastat) in Patients With Metastatic Renal Cell Carcinoma Refractory to Immunotherapy. Date Last Modified: 2002-04-01. ... Cancer.gov  Phase II Study of AE-941 (Neovastat) in Patients With Early Relapse or Refractory Multiple Myeloma. ... Patients receive oral AE-941 (Neovastat) twice daily. ... Cancer.gov - Angiogenesis Inhibitors in Clinical Trials  Drugs that block activators of angiogenesis: Drug, List of Active Clinical Trials. AE-941 (Neovastat™; GW786034), List of AE-941 trials. ... Cancer.gov - Cartilage (Bovine and Shark) (PDQ®)  A liquid (ie, aqueous) extract of shark cartilage, called AE-941/Neovastat, has also been reported to inhibit the growth of a variety of cancer cell types in ... Cancer.gov  ...years. The shark cartilage extract is called Neovastat, or AE-941, and is manufactured by Aeterna Laboratories, Quebec, Canada. ... Center for Cancer Research - Staff Pages  E, Dimitriadou V, Pepin MC, Courjal F, Ricard I, Poyet P, Falardeau P, Figg WD, Dupont E: The antiangiogenic agent neovastat (AE-941) inhibits vascular ... NSC, Agent Name "723227","(161-180)ESO-1" "726584","(H115D)VHL35" ...  ACRONYCINE" "335752","ACYCLOVIR" "246131","AD-32" "635386","ADA TRANSDUCED T CELL" "683550","ADENO-P53 (Ad5CMV-p53) [Advexin]" "706456","AE-941 (Aeterna Shark ... Center for Cancer Research - Staff Pages  F, Beaulieu E, Dimitriadou V, Pepin MC, Courjal F, Ricard I, Poyet P, Falardeau P, Figg WD, Dupont E.: The Antiangiogenic Agent AE-941 (Neovastat) Inhibits ...

Web cancer-help.org Home | Cancers | Treatments | Regional! | Vitamins | Vaccines | Health | Hospitals | About Lottery News Futures Trading News Copyright Cancer-Help.org 2003-2004. All Rights Reserved.